• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 结合蛋白 CELF1 和 ELAVL1 协同控制 CD44 的可变剪接。

The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44.

机构信息

Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes)-UMR 6290, F-35000 Rennes, France.

Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes)-UMR 6290, F-35000 Rennes, France; Univ Rennes, CNRS, Inserm, BIOSIT-UMS 3480, US_S 018, F-35000 Rennes, France.

出版信息

Biochem Biophys Res Commun. 2022 Oct 20;626:79-84. doi: 10.1016/j.bbrc.2022.07.073. Epub 2022 Jul 30.

DOI:10.1016/j.bbrc.2022.07.073
PMID:35973378
Abstract

CD44 mRNA contains nine consecutive cassette exons, v2 to v10. Upon alternative splicing, several isoforms are produced with different impacts on tumor biology. Here, we demonstrate the involvement of the RNA-binding proteins CELF1 and ELAVL1 in the control of CD44 splicing. We show by FRET-FLIM that these proteins directly interact in the nucleus. By combining RNAi-mediated depletion and exon array hybridization in HeLa cells, we observe that the exons v7 to v10 of CD44 are highly sensitive to CELF1 and ELAVL1 depletion. We confirm by RT-PCR that CELF1 and ELAVL1 together stimulate the inclusion of these exons in CD44 mRNA. Finally, we show in eight different tumor types that high expression of CELF1 and/or ELAVL1 is correlated with the inclusion of CD44 variable exons. These data point to functional interactions between CELF1 and ELAVL1 in the control of CD44 splicing in human cancers.

摘要

CD44 mRNA 包含九个连续的外显子盒,即 v2 到 v10。通过选择性剪接,可产生多种异构体,对肿瘤生物学产生不同的影响。在这里,我们证明了 RNA 结合蛋白 CELF1 和 ELAVL1 参与了 CD44 剪接的调控。通过 FRET-FLIM 实验,我们证明这些蛋白质在细胞核中直接相互作用。通过在 HeLa 细胞中结合 RNAi 介导的敲低和外显子芯片杂交实验,我们观察到 CD44 的 v7 到 v10 外显子对 CELF1 和 ELAVL1 的敲低非常敏感。通过 RT-PCR,我们证实 CELF1 和 ELAVL1 共同促进了这些外显子在 CD44 mRNA 中的包含。最后,我们在八种不同的肿瘤类型中表明,CELF1 和/或 ELAVL1 的高表达与 CD44 可变外显子的包含相关。这些数据表明 CELF1 和 ELAVL1 之间在人类癌症中 CD44 剪接的调控中存在功能相互作用。

相似文献

1
The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44.RNA 结合蛋白 CELF1 和 ELAVL1 协同控制 CD44 的可变剪接。
Biochem Biophys Res Commun. 2022 Oct 20;626:79-84. doi: 10.1016/j.bbrc.2022.07.073. Epub 2022 Jul 30.
2
CELF1 preferentially binds to exon-intron boundary and regulates alternative splicing in HeLa cells.CELF1 优先结合于外显子-内含子边界,并调节 HeLa 细胞中的可变剪接。
Biochim Biophys Acta Gene Regul Mech. 2017 Sep;1860(9):911-921. doi: 10.1016/j.bbagrm.2017.07.004. Epub 2017 Jul 19.
3
Distribution of alternative untranslated regions within the mRNA of the CELF1 splicing factor affects its expression.CELF1 剪接因子 mRNA 内非翻译区的分布影响其表达。
Sci Rep. 2022 Jan 7;12(1):190. doi: 10.1038/s41598-021-03901-9.
4
Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72.ATP 依赖性 DEAD 盒 RNA 解旋酶 p72 对可变剪接的调控
Mol Cell Biol. 2002 Aug;22(16):5698-707. doi: 10.1128/MCB.22.16.5698-5707.2002.
5
Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3.CD44可变外显子v3中的多位点双向外显子剪接增强子
RNA. 2007 Dec;13(12):2312-23. doi: 10.1261/rna.732807. Epub 2007 Oct 16.
6
Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins.CELF和MBNL蛋白对mRNA表达和剪接的拮抗调节。
Genome Res. 2015 Jun;25(6):858-71. doi: 10.1101/gr.184390.114. Epub 2015 Apr 16.
7
The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.CD44可变v9外显子包含一个对SR蛋白9G8、ASF/SF2和SRp20有反应的剪接增强子。
J Biol Chem. 2003 Aug 29;278(35):32943-53. doi: 10.1074/jbc.M301090200. Epub 2003 Jun 24.
8
Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.剪接因子Tra2-β1在乳腺癌中特异性诱导表达,并调控CD44基因的可变剪接。
Cancer Res. 2006 May 1;66(9):4774-80. doi: 10.1158/0008-5472.CAN-04-3294.
9
SR protein expression and CD44 splicing pattern in human breast tumours.人类乳腺肿瘤中的SR蛋白表达及CD44剪接模式
Breast Cancer Res Treat. 2003 May;79(1):75-82. doi: 10.1023/a:1023338718974.
10
The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.p53 诱导的 RNA 结合蛋白 ZMAT3 是一种剪接调节剂,可抑制结直肠癌细胞中致癌性 CD44 变体的剪接。
Genes Dev. 2021 Jan 1;35(1-2):102-116. doi: 10.1101/gad.342634.120. Epub 2020 Dec 17.

引用本文的文献

1
Best evidence linking the extracellular factor TGF-β to cancer-associated alternative splicing programs.将细胞外因子转化生长因子-β(TGF-β)与癌症相关可变剪接程序联系起来的最佳证据。
BBA Adv. 2024 Dec 18;7:100132. doi: 10.1016/j.bbadva.2024.100132. eCollection 2025.
2
LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44.长链非编码 RNA HOTAIRM1 通过调节 FTO 乙酰化依赖的 CD44 可变剪接促进鼻咽癌的放射抵抗性。
Neoplasia. 2024 Oct;56:101034. doi: 10.1016/j.neo.2024.101034. Epub 2024 Aug 10.
3
Assessing the Impact of Novel Exon 11 Variants on Pre-mRNA Splicing.
评估新型外显子 11 变异对前体 mRNA 剪接的影响。
Cells. 2024 May 11;13(10):824. doi: 10.3390/cells13100824.
4
RNA-binding proteins regulating the CD44 alternative splicing.调控CD44可变剪接的RNA结合蛋白
Front Mol Biosci. 2023 Dec 1;10:1326148. doi: 10.3389/fmolb.2023.1326148. eCollection 2023.
5
The Continuous Adaptive Challenge Played by Arboviruses: An In Silico Approach to Identify a Possible Interplay between Conserved Viral RNA Sequences and Host RNA Binding Proteins (RBPs).虫媒病毒的持续适应性挑战:一种鉴定保守病毒 RNA 序列与宿主 RNA 结合蛋白 (RBPs) 之间可能相互作用的计算方法。
Int J Mol Sci. 2023 Jul 4;24(13):11051. doi: 10.3390/ijms241311051.
6
GWAS-Top Polymorphisms Associated With Late-Onset Alzheimer Disease in Brazil: Pointing Out Possible New Culprits Among Non-Coding RNAs.巴西与晚发性阿尔茨海默病相关的全基因组关联研究顶级多态性:指出非编码RNA中可能的新罪魁祸首。
Front Mol Biosci. 2021 Jul 5;8:632314. doi: 10.3389/fmolb.2021.632314. eCollection 2021.
7
RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness.RNA 结合蛋白 CUGBP1 控制乳腺癌细胞分子亚型中 INSR 的剪接差异,并影响细胞侵袭性。
Carcinogenesis. 2020 Sep 24;41(9):1294-1305. doi: 10.1093/carcin/bgz141.